About NuCèlle Inc.
NuCèlle Inc. is a 100% wholly owned U.S. subsidiary of North American
Medical Services Inc., a Canadian Coporation whose common shares are
listed for trading on the TSX Venture Exchange.
NuCèlle's close association with the medical community, and the use
of its formulations by medical professionals such as dermatologists,
plastic surgeons, and other skin treatment specialists, has provided
the verification to substantiate clinical claims. It is in this
medically controlled climate of measurable patient improvement, that
each new NuCèlle formulation is tried, tested and approved.
The NuCèlle line of skin care formulations offer life-long skin
care solutions for all skin types, and are remarkably effective in
alleviating such skin conditions as Melasma, Rosacea,
Hyperpigmentation, and the "butterfly rash" associated with Lupus.
Another noticeable benefit is a smoother, clearer, and less lined
complexion.
The NuCèlle formulations feature Mandelic Acid, combined with
NuCèlle's own proprietary Marine Complex; providing "Irritation Free"
skin conditioning, which is excellent for patients with sensitive skin
who are unable to tolerate traditional glycolic acid products. Unique
to this AHA, Mandelic Acid exhibits anti-bacterial properties, which
help in the treatment of Acne and trouble-prone skin.
NuCèlle currently have two distinct product divisions within the
Company: NuCèlle RX, the "Physician Only" line of products ; and
NuCèlle Mandelic Marine Complex, the "Aesthetician Only" line of
products.
Product Fulfillment and Customer Service Operations are conducted
from NuCèlle's Vancouver, BC, Canada facilities. Product Formulation,
Research and Development, Manufacturing and Product Fill are completed
at one of the largest independent Cosmetic Laborities in the US.
NuCèlle's unique products are distributed world-wide, and are
currently available in the US, Canada, Thailand, UK, South Africa and
soon to be released in China, Singapore and Australia